AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Intuitive Surgical Inc. Takes a Dive: Key Insights and Analyst Expectations
ByAinvest
Monday, Jul 7, 2025 7:10 pm ET1min read
Intuitive Surgical, Inc. (ISRG) closed at $534.65, down 1.8% from the previous day. The company's quarterly earnings are expected to be $1.92, a 7.87% increase from the same quarter last year. Annual earnings are forecasted at $7.84 per share, a 6.81% increase from the previous year. The Zacks Rank is #2 (Buy), and the Forward P/E ratio is 69.44, which is higher than the industry's Forward P/E of 25.22.
Intuitive Surgical, Inc. (ISRG), a leading provider of robotic surgical systems, closed at $534.65 on July 2, 2025, marking a 1.8% decline from the previous day's close. This drop was slightly more pronounced than the broader market, where the S&P 500 lost 0.79%, the Dow dropped 0.94%, and the Nasdaq fell 0.92%. Over the past month, ISRG's stock has underperformed the Medical sector, with a 2.26% loss compared to the sector's 1.49% gain and the S&P 500's 5.22% increase.Looking ahead, investors are anticipating ISRG's upcoming earnings disclosure. Analysts predict the company will report earnings per share (EPS) of $1.92, representing a 7.87% increase from the same quarter last year. For the full year, the Zacks Consensus Estimates forecast EPS of $7.84 per share, a 6.81% increase from the previous year. Revenue is expected to reach $2.35 billion in the quarter, up 16.81% year-over-year, and $9.65 billion for the year, a 15.56% increase [1].
ISRG's valuation metrics indicate a premium over the industry average. The company is trading at a Forward P/E ratio of 69.44, significantly higher than the Medical - Instruments industry's Forward P/E of 25.22. The PEG ratio, which accounts for expected earnings growth, stands at 4.59, compared to the industry average of 2.26 [1].
The Zacks Rank, an exclusive model that considers changes in analyst estimates, currently rates ISRG as a #2 (Buy) [1]. This ranking reflects a positive outlook on the company's business operations and ability to generate profits.
In summary, while ISRG's recent stock performance has lagged the broader market, the company's strong earnings forecasts and premium valuation metrics suggest a potential for recovery and growth in the coming quarters.
References:
[1] https://www.nasdaq.com/articles/intuitive-surgical-inc-isrg-suffers-larger-drop-general-market-key-insights-1
[2] https://stockanalysis.com/stocks/isrg/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet